Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
HIV
Sort By
Newest First
1 / 2
1 / 2
Therapeutic Candidate
CytoDyn Takes Steps towards a Brighter Future
Cyrus Arman, Ph.D.
CytoDyn
PAO-02-23-CL-04
Feb 06, 2023
Collaboration
ViiV Healthcare and Halozyme Enter Global Collaboration for ENHANZE® Drug Delivery Technology to Enable Development of “Ultra Long-Acting” Medicines for HIV
GSK
PR-M06-21-032
Jun 25, 2021
HIV Prevention
Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine with the Imbokodo Study
Johnson & Johnson
PR-M07-20-NI-026
Jul 16, 2020
HIV
ViiV Healthcare’s Injectable Formulation Dosed Every Two Months Shows Higher Efficacy than Daily Oral PrEP
GSK
PR-M05-20-NI-034-1543
May 22, 2020
HIV
NIH Launches New Collaboration to Develop Gene-based Cures for Sickle Cell Disease and HIV on Global Scale
National Institutes of Health (NIH)
PR-M10-19-NI-033
Oct 24, 2019
HIV Prevention
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic
The US Food & Drug Administration
PR-M10-19-NI-008
Oct 07, 2019
Vaccine
HIV Vaccine to be Tested in the U.S. and Europe
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-008
Aug 01, 2019
HIV/AIDS
Upcoming HIV Study to Focus on Chronic Conditions Affecting People with AIDS
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M06-19-NI-013
Jun 20, 2019
HIV
Gilead Sciences to Provide Free Truvada for PrEP® to Support U.S. Initiative to End the HIV Epidemic
Gilead Sciences
PR-M05-19-NI-038
May 14, 2019
Prequalification Approval
Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
Abbott
PR-M05-19-NI-017
May 06, 2019
Funding
Mymetics receives HIV Vaccine Funding from the NIH
Texas Biomed
PR-M05-19-NI-004
May 01, 2019
Clinical Data
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
United BioPharma
PR-M04-19-NI-066
Apr 22, 2019
HIV Prevention
Descovy Shown to be As Effective and Safer than Truvada as a Preventive HIV Treatment
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M04-19-NI-011
Apr 10, 2019
HIV
Long-Acting Injectable HIV Treatment Regimen of Rilpivirine and Cabotegravir Demonstrated Comparable Safety and Efficacy to Daily Oral HIV Therapy
Johnson & Johnson
PR-M03-19-NI-033
Mar 12, 2019
FDA Approval
GSK’s ViiV Healthcare Seeks FDA Approval for Combination HIV Therapy
Emilie Branch
Pharma's Almanac
PAO-M10-18-NI-029
Oct 29, 2018
HIV Diagnoses
Gilead Announces New Data on the Impact of Truvada® for Pre-Exposure Prophylaxis (PrEP) on the Number of HIV Diagnoses in the United States
Gilead Sciences
PR-M07-18-NI-087
Jul 26, 2018
HIV Therapy
Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine
Merck & Co.
PR-M07-18-NI-083
Jul 25, 2018
Drug Development
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Mylan
PR-M03-18-NI-023
Mar 07, 2018
Gilead Announces Data from New Preclinical Study Evaluating a Combination of an Investigational TLR7 Agonist and an Investigational HIV Envelope
Gilead Sciences
PR-M03-18-NI-021
Mar 06, 2018
Clinical Data
Merck to Present New Data from Studies of Investigational HIV Therapies Doravirine and MK-8591 at CROI 2018
Merck & Co.
PR-M03-18-NI-015
Mar 05, 2018
